ENOV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. While ENOV is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on ENOV.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year ENOV was profitable.
ENOV had a positive operating cash flow in the past year.
In multiple years ENOV reported negative net income over the last 5 years.
ENOV had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

ENOV has a Return On Assets (-30.84%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -67.66%, ENOV is in line with its industry, outperforming 45.41% of the companies in the same industry.
With a decent Return On Invested Capital value of 0.12%, ENOV is doing good in the industry, outperforming 64.86% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-30.84%
ROE	-67.66%
ROIC	0.12%

ROA(3y)-6.18%

ROA(5y)-3.42%

ROE(3y)-11.19%

ROE(5y)-6.16%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of ENOV (0.25%) is better than 64.86% of its industry peers.
ENOV's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 57.19%, ENOV perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
ENOV's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	0.25%
PM (TTM)	N/A
GM	57.19%

OM growth 3YN/A

OM growth 5Y-43.59%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.41%

GM growth 5Y6.07%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ENOV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ENOV has been increased compared to 1 year ago.
ENOV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ENOV is higher compared to a year ago.

2.2 Solvency

ENOV has an Altman-Z score of 0.71. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.71, ENOV is in line with its industry, outperforming 48.65% of the companies in the same industry.
ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
ENOV has a better Debt to FCF ratio (59.72) than 67.03% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.66, ENOV is not doing good in the industry: 64.86% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	0.66
Debt/FCF	59.72
Altman-Z	0.71

ROIC/WACC0.01

WACC9.7%

2.3 Liquidity

ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
ENOV has a Current ratio (2.22) which is in line with its industry peers.
A Quick Ratio of 1.16 indicates that ENOV should not have too much problems paying its short term obligations.
ENOV has a Quick ratio of 1.16. This is in the lower half of the industry: ENOV underperforms 69.19% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.22
Quick Ratio	1.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.14%, which is quite impressive.
The earnings per share for ENOV have been decreasing by -16.18% on average. This is quite bad
The Revenue has grown by 11.57% in the past year. This is quite good.
ENOV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.73% yearly.

EPS 1Y (TTM)26.14%

EPS 3Y-23.78%

EPS 5Y-16.18%

EPS Q2Q%2.74%

Revenue 1Y (TTM)11.57%

Revenue growth 3Y13.9%

Revenue growth 5Y-8.73%

Sales Q2Q%8.65%

3.2 Future

The Earnings Per Share is expected to grow by 23.19% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.87% on average over the next years. This is quite good.

EPS Next Y14.57%

EPS Next 2Y11.17%

EPS Next 3Y11.67%

EPS Next 5Y23.19%

Revenue Next Year7.37%

Revenue Next 2Y5.98%

Revenue Next 3Y6.01%

Revenue Next 5Y8.87%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.62, which indicates a rather cheap valuation of ENOV.
Based on the Price/Earnings ratio, ENOV is valued cheaply inside the industry as 98.38% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.32, ENOV is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.30, the valuation of ENOV can be described as very cheap.
98.92% of the companies in the same industry are more expensive than ENOV, based on the Price/Forward Earnings ratio.
ENOV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.57.

		Industry Rank	Sector Rank
PE	6.62
Fwd PE	6.3

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaper than 93.51% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ENOV indicates a somewhat cheap valuation: ENOV is cheaper than 72.97% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	55.37
EV/EBITDA	8.69

4.3 Compensation for Growth

ENOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)0.45

PEG (5Y)N/A

EPS Next 2Y11.17%

EPS Next 3Y11.67%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ENOV!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ENOVIS CORP / ENOV FAQ

What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ENOV.

What is the valuation status of ENOVIS CORP (ENOV) stock?

ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.

Can you provide the profitability details for ENOVIS CORP?

ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.

What is the earnings growth outlook for ENOVIS CORP?

The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.57% in the next year.